Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Boyuan Medical Technology Development is a Chinese medical device company specializing in the research, development, and manufacturing of cardiovascular interventional products. Founded in 2004 and headquartered in Dalian, the company focuses on providing high-quality and affordable solutions for the treatment of coronary artery disease. Its core product portfolio includes cobalt-chromium alloy coronary stents, rapamycin-eluting stents, and PTCA balloon dilatation catheters, all of which have received regulatory approval from the NMPA. As a recognized high-tech enterprise, Dalian Boyuan integrates advanced manufacturing processes with clinical research to serve the domestic interventional cardiology market. The company maintains a strong commitment to innovation in vascular implants and interventional accessories. Its products are widely utilized in hospitals across China for percutaneous coronary intervention procedures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian Boyuan Medical Technology Development.